HIV TREATMENT DRUGS
Rich hopes as the poor watch The United States’ Food and Drug Administration (FDA) has approved twice-a-year injections and tablets for treating HIV in adults with multi-drug resistant infection. Media groups term this as hopes while majority of the world take it as news of the hot air that will evaporate eventually due to the unaffordable high cost of the drug. It's said that the drug will cost $42,250 (5.1 million) for the two shots, with users then required to fork out $39,000 (4.7 million) a year for maintenance shots. Is HIV a natural calamity or a weapon formed in labs and now an economic bait. Since there is urrently, a similar drug called Cabenuva (cabotegravir and rilpivirine) from the United Kingdom’s GSK, which became the first FDA-approved injectable for HIV in 2021 that, costs $40,000 to $50,000 (Sh4.9 million to Sh6.1 million) a year. The US ought to have upgraded their inventory for a vaccine or a full treatment drose. But the main concern is prices of t...